Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001695028-26-000010

Chief Financial Officer sold 13,400 shares at $13.53 ($181,258)

  • Chief Financial Officer acquired 13,400 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Piscitelli Dominic Chief Financial Officer 2026-09-28 Option exercise 10b5-1 +13,400 $4.36 $58,424 83,228 D: show line 1 in the form
Piscitelli Dominic Chief Financial Officer 2026-09-28 Sale 10b5-1 −13,400 $13.53 $181,258 69,828 D: show line 2 in the form
Open-market sales · 13,400 sh · avg $13.53 · $181,258

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Piscitelli Dominic Chief Financial Officer 2026-09-28 Option exercise · Stock Option (right to buy) 10b5-1 −13,400 78,500 D: show line 3 in the form
Loading xslF345X06/form4-09292026_110919.xml…